The functional role of heteromers of G-protein-coupled receptors is a matter of debate. In the present study, we demonstrate that
Introduction
Of the four known adenosine receptors (A 1 , A 2A , A 2B , and A 3 ), A 1 receptor (A 1 R) and A 2A receptor (A 2A R) are primarily responsible for the central effects of adenosine (Dunwiddie and Masino, 2001) . The same receptors are also the main target of nontoxic psychostimulant doses of caffeine, the most consumed psychoactive drug in the world . In addition to their postsynaptic location in different brain regions, A 1 R and A 2A R can be found presynaptically. A 1 R and A 2A R are coupled to G i/oand G s/olf -proteins, respectively (Dunwiddie and Masino, 2001) . Stimulation of presynaptic A 1 Rs receptors decreases the probability of neurotransmitter release, whereas activation of presynaptic A 2A Rs enhances neurotransmitter release (Yawo and Chuhma, 1993; Wu and Saggau, 1997; O'Kane and Stone, 1998; Lopes et al., 2002; Quarta et al., 2004b) .
Previous studies have provided evidence for functional antagonistic interactions between A 1 Rs and A 2A Rs that modulate glutamate release in the striatum and hippocampus (O'Kane and Stone, 1998; Lopes et al., 2002; Quarta et al., 2004b) . The coexistence of both facilitatory A 2A Rs and inhibitory A 1 Rs in the same terminal is intriguing, particularly in view of their opposite functional effects. In the present study, we use radioligand-binding, coimmunoprecipitation, bioluminescence resonance energy transfer (BRET) and time-resolved fluorescence resonance energy transfer (TR-FRET) techniques to demonstrate that A 1 R and A 2A R form A 1 R-A 2A R heteromers in mammalian cells and in striatal glutamatergic nerve terminals. The main biochemical characteristic of the A 1 R-A 2A R heteromer is the ability of A 2A R activation to reduce the affinity of the A 1 R for agonists, providing a switch mechanism by which low and high concentrations of adenosine inhibit and stimulate, respectively, glutamatergic neurotransmission. The present study is the first indication that heteromerization of different receptors for the same modulator constitutes a unique way to presynaptically regulate neurotransmission and also is the first indication that A 1 R-A 2A R heteromers may be involved in the acute and chronic effects of caffeine.
Materials and Methods
Animals, cell culture, and transfection. Male Sprague Dawley or Wistar rats (Charles River Laboratories, Wilmington, MA) were used, where indicated. Caffeine was administered chronically by giving free access to bottles containing a solution of 1.0 mg/ml caffeine anhydrate base (Sigma, St. Louis, MO) in tap water for 14 d (chronic group) as the only fluid available for drinking. HEK-293 cells were grown in DMEM (Sigma) as described previously Canals et al., 2003) . All animal experiments were performed in accordance with the National Institutes of Health and Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research (National Research Council, 2003) . Cells were transiently transfected with the DNA encoding for the proteins specified in each case by calcium phosphate precipitation. The human hemagglutinin (HA)-A 2A R and Flag-A 1 R construct were obtained as previously described Canals et al., 2003) . These receptors were also subcloned in frame with either Renilla luciferase (A 2A R-Rluc) or with the enhanced yellow fluorescent protein (A 1 R-YFP).
Immunoprecipitation and Western blot analysis. Transiently transfected HEK cells or striatal synaptosomes were solubilized in ice-cold lysis buffer [PBS, pH 7.4, containing 1% (v/v) for 30 min on ice. The solubilized preparation was then centrifuged at 13,000 ϫ g for 30 min, and the supernatant (1 mg/ml) was processed for immunoprecipitation, as described previously Canals et al., 2003) . Immune complexes in sample buffer (8 M urea, 2% SDS, 100 mM DTT, 375 mM Tris, pH 6.8) were dissociated by heating to 37°C for 2 h and resolved by SDS-PAGE. Proteins were transferred to polyvinylidene difluoride membranes using a semidry transfer system and immunoblotted with the indicated primary antibody. The blots were then incubated with a secondary horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG antibody (1:60,000). The immunoreactive bands were developed using a chemiluminescent detection kit. The primary antibodies used were as follows: anti-Flag monoclonal antibody and anti-HA monoclonal antibody (Sigma) and rabbit anti-A 2A R and anti-A 1 R polyclonal antibodies (Affinity BioReagents, Golden, CO). To test the specificity of the anti-A 1 R polyclonal antibody in striatal tissue, a preincubation with the immunizing peptide C(309)QPKPPIDEDLPEEKAED(326) (ab5893; Abcam, Cambridge, MA) was performed. This preincubation completely abrogated the staining observed in striatal tissue (data not shown).
Immunostaining. For immunochemistry, transiently transfected HEK cells or rat striatal synaptosomes were fixed in 4% paraformaldehyde for 15 min and washed with PBS containing 20 mM glycine (buffer A) to quench the aldehyde groups. Then, after permeabilization with buffer A containing 0.2% Triton X-100 for 5 min, cells or striatal synaptosomes were treated with PBS containing 1% bovine serum albumin (buffer B). After 1 h at room temperature, cells or synaptosomes were labeled with the indicated primary antibody for 1 h, washed, and stained with the indicated secondary antibody. Samples were rinsed and observed in a confocal microscope Canals et al., 2003; Rodrigues et al., 2005) . The primary antibodies used were as follows: anti-HA monoclonal antibody (2 g/ml; Sigma), rabbit anti-Flag polyclonal antibody (2 g/ml; Sigma), mouse anti-A 2A R (2 g/ml; Upstate Biotechnology, Lake Placid, NY), rabbit anti-A 1 receptor (1:200; Affinity Bioreagents), guinea pig anti-vGluT1 (1:5000; Chemicon, Temecula, CA) and guinea pig anti-vGluT2 (1:5000; Chemicon). The secondary antibodies used were as follows: Alexa Fluor 488-conjugated goat anti-mouse IgG (1:200; Invitrogen, Eugene, OR), Texas Red-conjugated goat anti-rabbit IgG (1:1000; Invitrogen), Alexa Fluor 598-conjugated goat anti-guinea pig (1:200; Invitrogen), and Alexa Fluor 350-conjugated goat anti-rabbit (1:200; Invitrogen). For ultrastructural analysis, preembedding techniques for single and double labeling were used, as described previously (Lujan et al., 1996) . Briefly, free-floating sections were incubated in Trisbuffered saline containing 10% of normal goat serum (TBS-NGS) during 1 h. After blocking, sections were incubated during 48 h with TBS-NGS containing mouse anti-A 2A R antibody (2 g/ml; Upstate Biotechnology) and/or rabbit-anti-A 1 R antibody (2 g/ml; Affinity Bioreagents). When a single primary antibody was used, it was visualized by the silverintensified immunogold reaction. When two primary antibodies were used, one of them (anti-A 2A R antibody) was visualized by the immunoperoxidase reaction and the second one (anti-A 1 R antibody) by the silver-intensified immunogold reaction. The following secondary antibodies were used: goat anti-rabbit coupled to 1.4 nm gold, goat anti-mouse coupled to 1.4 nm gold, and biotinylated goat anti-mouse antibody. After washing in TBS, sections were processed and observed as described previously (Lujan et al., 1996) .
BRET and TR-FRET. Forty-eight hours after transfection, HEK cells were rapidly washed twice in PBS, detached, and resuspended in the same buffer. The protein was determined using a Bradford assay kit (Bio-Rad, Hercules, CA). To quantify A 2A R-Rluc and A 1 R-YFP expression, a cell suspension (20 g of protein) was distributed in duplicate into 96-well transparent bottom microplates (Corning, Corning, NY). The fluorescence and luminescence were determined as described previously (Canals et al., 2003) . For BRET measurement, 20 g of cell suspension was distributed in duplicate in 96-well opaque microplates (Corning) and 5 mM coelenterazine H was added. After 1 min, the readings were collected by using a Fusion microplate analyzer (Packard, Meridian, CT) that allows the integration of the signals using filters with the appropriate bandpass. The BRET ratio is defined as [(emission at 510 -590)/(emission 440 -500)] Ϫ cf., where cf. corresponds to (emission at 510 -590)/ (emission at 440 -500) for the A 2A R-Rluc construct expressed alone in the same experiment. Time-resolved FRET was performed as described previously (McVey et al., 2001) . Briefly, transiently transfected HEK cells were detached, washed twice with PBS, and incubated in PBS containing 50% fetal bovine serum and 5 nM Eu 3ϩ -labeled anti-Flag antibody (CIS bio, Gif/Yvette, France) and 20 nM allophycocyanin-labeled anti-HA antibody (CIS bio) during 3 h in constant rotation at room temperature. After washing, cells were placed into a 96-well microtiter plate and analyzed using a Victor 2 (PerkinElmer, Wellesley, MA) configured for timeresolved fluorescence.
Radioligand-binding experiments. Membrane suspensions from rat striatum or from transfected HEK cells were obtained as described previously (Casadó et al., 1990; Herrera et al., 2001) . Displacement experiments were performed by incubating (120 min) membranes (0.25 mg/ml striatal protein or 0.19 mg/ml HEK cells) at 25°C in 50 mM Tris-HCl buffer, pH 7.4, containing 10 mM MgCl 2 and 2 U/ml adenosine deaminase (EC 3.5.4.4; Roche, Basel, Switzerland) (Sarrió et al., 2000) . Nonspecific binding was determined in the presence of 10 M 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) (Sigma) for A 1 Rs or 10
,5]triazin-5-ylamino]ethyl)phenol) (Tocris, Ellisville, MO) for binding to A 2A Rs. Free and membrane-bound ligand were separated and detected as described previously (Casadó et al., 1990; Sarrió et al., 2000; Herrera et al., 2001) . Radioligand displacement curves were analyzed by nonlinear regression using commercial program GRAFIT (Erithacus Software, Surrey, UK) by fitting the total binding data to the displacement models with one-or two-affinity sites (Cheng and Prusoff, 1973; Casadó et al., 1992) . Values are parameter Ϯ SEM and differences with respect to controls were tested for significance ( p Ͻ 0.05) using Student's t test for unpaired samples. Goodness of fit was tested according to reduced 2 value given by the nonlinear regression program GRAFIT. A modified F test was used to analyze whether the fit to the two-site model significantly improved on the fit to one-site model, and p Ͻ 0.05 was taken as a criterion of significance; when no significant improvement over the one-site model was detected, the p values were Ͼ0.30.
Calcium determination. Transiently transfected HEK cells (10 6 cells/ ml) were loaded with 5 mM fura-2 AM for 30 min at 37°C. After washing the cells, calcium peak induction was achieved by the addition of 50 nM R-PIA and/or 200 nM CGS21680. Intracellular calcium was determined as described previously .
Striatal synaptosomes preparation and measurement of evoked [ 3 H]glutamate release. Striatal synaptosomes prepared for immunocytochemical analysis were obtained through a discontinuous Percoll gradient (Ro-drigues et al., 2005) . The release of [ 3 H]glutamate from rat striatal nerve terminals was performed as described previously (Lopes et al., 2002; Rodrigues et al., 2005) . The synaptosomes were stimulated with 20 mM K ϩ (isomolar substitution of NaCl by KCl in the Krebs' solution) at 3 and 9 min after starting sample collection (S 1 and S 2 ). Tested drugs were added 2 min before S 2 onward, whereas modifiers present in S1 and S2 were added from 10 min before starting sample collection onward. Radioactivity was expressed in terms of disintegrations per second per milligram of protein (becquerels per milligram) in each chamber. The percentage of modification of the evoked release caused by the tested drugs was determined by measuring the percentage of modification of the ratio S2/S1 in comparison with the ratio S2/S1 of the respective control. Adenosine (0.1-100 M), N 6 -cyclopentyladenosine (CPA) (100 nM), CGS (10 nM), DPCPX (50 nM), and 5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine (SCH58261) (50 nM), when present during S1 and S2, did not cause any effect per se on the S2/S1 ratio. We further confirmed that the presence of either CPA or CGS21680 during S1 and S2 did not lead to a desensitization of the A 1 R-mediated or A 2A R-mediated modulation of glutamate release; in fact, when applied during S1 and S2, CGS21680 (10 nM) enhanced glutamate release by 28.5 Ϯ 1.8% during S1 and by 34.9 Ϯ 3.6% during S2, whereas CPA (100 nM) inhibited glutamate release by 10.8 Ϯ 0.7% during S1 and by 10.4 Ϯ 1.0% during S2 (n ϭ 6). (Fig. 1a) . Conversely, in extracts from these cells, the anti-HA antibody coimmunoprecipitated a band of ϳ38 kDa corresponding to the Flag-A 1 R (Fig. 1a) .
Results

A
A 1 R-A 2A R heteromerization was tested using BRET assays. A positive and saturable BRET signal for the transfer of energy between A 2A R-Rluc and A 1 R-YFP was obtained (Fig. 1b ) in cells cotransfected with a constant concentration of the A 2A R-Rluc and increasing concentrations of A 1 R-YFP. As the pair A 2A RRluc and GABA receptor GABA B2 -YFP led to an undetectable BRET signal (Fig. 1b) , the hyperbolic BRET signal found for the A 2A R-Rluc plus A 1 R-YFP argues for the selectivity of the interaction between A 1 Rs and A 2A Rs, and also suggest that the distance between donor (A 2A R-Rluc) and acceptor (A 1 R-YFP) is Յ10 nm. To assess whether these A 1 R-A 2A R heteromers occur at the plasma membrane level, TR-FRET was assayed in cells cotransfected with Flag-A 1 Rs and HA-A 2A Rs. Because Flag and HA tags were localized extracellularly at the N terminus of these receptors, only the A 1 Rs and A 2A Rs localized at the plasma membrane of intact cells were detected and gave a positive strong TR-FRET signal (acceptor/donor emission, mean Ϯ SEM, 0.081 Ϯ 0.002; n ϭ 3) compared with a mixture of cells previously transfected with only A 1 Rs or A 2A Rs and then mixed before the assays (acceptor/donor emission, 0.011 Ϯ 0.002; n ϭ 3). Confocal microscopy analysis of nonpermeabilized HEK cells transfected with the cDNAs for Flag-A 1 Rs and HA-A 2A Rs confirmed an overlapped distribution of the two proteins on the cell surface (Fig. 1c) . A 2A Rs displayed higher affinity for caffeine than A 1 Rs (Table 1) . Interestingly, the affinity of A 2A Rs for caffeine in A 1 R-A 2A Rcotransfected cells was 12-fold lower to that compared with A 2A R-transfected cells ( p Ͻ 0.001) ( Table 1 ). The affinity of the A 2A R for CGS21680 and caffeine was not altered when cotransfected with the dopamine D 2 receptor (D 2 R), although they form A 2A R-D 2 R heterodimers (Canals et al., 2003) (Table 1) .
In cells cotransfected with both A 1 Rs and A 2A Rs, but not in cells expressing only A 1 Rs, the affinity of A 1 Rs for [ 3 H]R-PIA decreased in the presence of the A 2A R agonist CGS21680, indicating that A 2A R activation reduces the affinity of A 1 R for its agonist. As illustrated in Figure 2a , the displacement of [ 3 H]R-PIA by CGS21680 in membranes from A 1 R-A 2A R-cotransfected cells was significantly ( p Ͻ 0.01) better fitted by a two-site model than by a single-site model (Fig. 2a, solid vs dashed line) , whereas it was better fitted ( p Ͻ 0.01) to a single-site model rather than a two-site model in membranes from A 1 R single-transfected cells (Fig. 2b, solid vs dashed line) . At low concentrations of CGS21680, when it binds preferentially to A 2A Rs (at concentrations of CGS21680 Ͻ500 nM, the direct binding of CGS21680 to A 1 Rs is Ͻ1%, according to the calculated affinity of A 1 R for CGS21680), CGS21680 significantly ( p Ͻ 0.05) decreased the binding of [ 3 H]R-PIA to the A 1 R from an EC 50 value of 3.0 Ϯ 0.4 M to 30 Ϯ 10 nM (means Ϯ SEM). The EC 50 value corresponds to one-half of the maximum inhibitory effect of CGS21680 on the binding of [ 3 H]R-PIA to the A 1 R (or the high-affinity site calculated using the two-site model). In contrast, the displacement of [ The ability of A 2A Rs to decrease A 1 R-mediated effects after formation of the A 1 R-A 2A R heterodimer was confirmed in experiments measuring intracellular calcium levels in HEK cells transiently expressing Flag-A 1 Rs plus HA-A 2A Rs. The intracellular calcium peak induced by the A 1 R agonist, R-PIA (50 nM), was similar in HEK cells transfected with A 1 R alone or A 1 R plus A 2A R (Fig. 2c) (95 Ϯ 15 and 86 Ϯ 12 nM, respectively). However, preincubation with 50 nM CGS21680, which was by itself ineffective, significantly reduced the calcium peak obtained in response to A 1 R activation in cells doubly transfected with both receptors (Fig. 2c) to 41 Ϯ 16 nM. This contrasted with the inability of CGS21680 (50 nM) to affect A 1 R-mediated recruitment of intracellular calcium in cells expressing only Flag-A 1 Rs. R-PIA (50 nM) or CGS21680 (50 nM) failed to modify intracellular calcium levels in nontransfected HEK-293 cells (Fig. 2c) .
A 1 R-A 2A R heteromers in rat striatum
Immunoelectron microscopy, using preembedding immunogold techniques, revealed the presence of A 2A R immunoreactivity along the extrasynaptic plasma membrane of axon terminals establishing asymmetric synapses (Fig. 3a) , as well as in the presynaptic active zone of asymmetric synapses facing dendritic shafts and spines (Fig. 3b) . A 2A Rs were also observed in postsynaptic structures along the extrasynaptic and perisynaptic plasma membrane of dendritic shafts and spines, establishing asymmetrical synapses with axon terminals (Fig. 3a-c) . Similarly, immunoreactivity for the A 1 R was localized along the extrasynaptic plasma membrane and presynaptic active zone of axon terminals in asymmetric synapses and along the extrasynaptic plasma membrane of dendritic shafts and spines (Fig. 3d,e) establishing asymmetrical synapses with axon terminals. Interestingly, both receptors colocalized in both presynaptic and postsynaptic structures of asymmetrical, putative glutamatergic, synapses (Fig. 3f-h) . This is the first direct anatomic evidence for adenosine A 2A Rs and A 1 Rs colocalization in the same neuronal compartments.
To test the presence of A 1 R-A 2A R heteromers in the rat striatum, competitive-inhibition experiments by CGS21680 of [ 3 H]R-PIA binding were also performed in membrane preparations from rat striatum. As observed in cells cotransfected with A 1 Rs and A 2A Rs, the obtained displacement data in rat striatal membranes were significantly ( p Ͻ 0.001) better fitted by a twosite model than by a single-site model (Fig. 4a) . The IC 50 value, which reflects the binding of CGS21680 directly to the A 1 R (lowaffinity site calculated using the two-site model), and the EC 50 value, which refers to the effect of CGS21680 on the binding of R-PIA to A 1 R (high-affinity site calculated using the two-site model) were 1.8 Ϯ 0.5 M and 22 Ϯ 6 nM, respectively (means Ϯ SEM). These values were strikingly similar to those obtained using A 1 R-A 2A R-cotransfected cells (3.0 Ϯ 0.4 M and 30 Ϯ 10 nM, respectively). The activation of A 1 R with R-PIA did not modify the affinity of A 2A R for its agonist CGS21680 in rat striatal membranes (data not shown), as observed in cells cotransfected with A 1 Rs and A 2A Rs. Another correlate of the existence of A 1 R-A 2A R heteromers in the striatum, based on the findings obtained in cells cotransfected with A 1 Rs and A 2A Rs, was that the affinity of rat striatal A 2A Rs for caffeine was four times lower than the affinity of A 1 Rs for caffeine (see below).
A 1 R-A 2A R heteromeric complexes in striatal glutamatergic nerve terminals
The preferential colocalization of A 1 R and A 2A R in glutamatergic terminals was confirmed by immunocytochemistry and coimmunoprecipitation. A 1 R and A 2A R immunoreactivity could be detected in single glutamatergic nerve terminals, identified by immunostaining using antibodies against vesicular glutamate transporters type 1 and 2 (vGluT1 and vGluT2), which are expressed in glutamatergic neurons (Fremeau et al., 2001; Herzog et al., 2001) (Fig. 5a) . Quantification of images (n ϭ 4) showed that there is a 61 Ϯ 2% (in means Ϯ SEM) of glutamatergic terminals that are immunoreactive for both A 1 Rs and A 2A Rs, whereas only 1.5 Ϯ 0.9% are endowed with A 2A Rs but not with A 1 Rs and 9 Ϯ 1% with A 1 Rs but not with A 2A Rs (Fig. 5b) . The number of glutamatergic terminals that do not express any of the receptors is Ͻ30%. As shown in Figure 5c , an antibody against A 2A Rs was able to immunoprecipitate A 1 Rs from solubilized rat striatal nerve terminals. These results demonstrate that A 1 Rs and A 2A Rs can form heteromeric receptor complexes in the striatal nerve terminals.
To prove a direct effect of presynaptic A 1 R and A 2A R on glutamate release, the evoked release of glutamate was analyzed from superfused rat striatal nerve terminals loaded with [ 3 H]glutamate. The A 1 R agonist CPA (100 nM) inhibited (mean Ϯ SEM; 31.6 Ϯ 2.6%, n ϭ 3) the K ϩ -evoked [ 3 H]glutamate release and this effect was prevented by preincubation with the selective A 1 R antagonist DPCPX (50 nM) (Fig. 6a) , which did not have any significant effect on its own (data not shown). The inhibitory effect of CPA was also prevented when synaptosomes were preincubated with the A 2A R agonist CGS21680 (10 nM) (Fig. 6a) , showing the A 2A Rmediated negative modulation of A 1 R function, as occurred in HEK cells. In contrast, CGS21680 facilitated (57.7 Ϯ 6.4%; n ϭ 3) the K ϩ -evoked [ 3 H]glutamate release, and this effect was prevented by the selective A 2A receptor antagonist SCH58261 (50 nM) but was not modified when synaptosomes were preincubated with CPA (Fig. 6a) . SCH58261 alone did not have any effect on glutamate release (data not shown). When CGS21680 (10 nM) and CPA (100 nM) were simultaneously added, a facilitatory effect was obtained (44.5 Ϯ 8.6%; n ϭ 6), which was significantly ( p Ͻ 0.05) higher than the arithmetic sum of the separate effects of 10 nM CGS21680 and 100 nM CPA (i.e., if these effects were purely additive), as illustrated by the dashed bar in Figure 6a . Overall, these results agree with the occurrence of functional A 1 R-A 2A R heteromers in striatal glutamatergic nerve terminals testified by the ability of A 2A Rs to abrogate A 1 R-mediated effects.
Finally, the addition of increasing concentrations of adenosine (0.1-100 M) demonstrated its ability to biphasically modulate the evoked release of glutamate from striatal nerve terminals. At a concentration of 0.1 M, adenosine did not significantly modify glutamate release (n ϭ 6); at 1 M, adenosine significantly decreased (23.6 Ϯ 4.7%; n ϭ 8; p Ͻ 0.05), whereas, at 10 and 100 M, it significantly facilitated K ϩ -evoked [ 3 H]glutamate (30.4 Ϯ 7.5 and 17.6 Ϯ 3.5%; n ϭ 6; p Ͻ 0.05 in both cases).
A 1 R-A 2A R intramembrane interaction and caffeine tolerance
An unresolved issue about caffeine is the strong tolerance for many of its behavioral and biochemical effects that develop after chronic treatment (Holtzman and Finn, 1988 ; Jacobson et al., 1996; Fredholm et al., 1999) . To test a possible role of A 1 R-A 2A R heteromers in this phenomenon, competitive-inhibition experiments of [ 3 H]R-PIA binding using CGS21680 were performed in striatal membrane preparations of caffeine-treated rats (1 mg/ml in the drinking water for 14 d; average caffeine consumption, mean Ϯ SEM, 120 Ϯ 4 mg ⅐ kg Ϫ1 ⅐ d Ϫ1 ), and the results compared with those obtained in naive animals. Again, the displacement curve of [ 3 H]R-PIA binding by CGS21680 in striatal membranes from caffeine-treated rats was significantly ( p Ͻ 0.001) better fitted by a two-site model than by a single-site model (Fig.  4b) . The IC 50 value (mean Ϯ SEM) corresponding to the binding of CGS21680 to A 1 R (1.7 Ϯ 0.5 mM) was similar to that obtained in naive rats (1.8 Ϯ 0.5 M) as well as the [ 3 H]R-PIA binding to these striatal membranes when no displacer was present (Fig. 4) . However, the inhibition of the 3 H]glutamate, were chemically (20 mM K ϩ for 30 s) stimulated twice (S1 and S2). a, CPA (100 nM) and CGS21680 (10 nM), present in S2, inhibited and facilitated, respectively, the evoked release of glutamate in a manner prevented by the A 1 R and A 2A R antagonists DPCPX (50 nM) and SCH58261 (50 nM), respectively (present in S1 and S2). The inhibitory effect of CPA (100 nM) was also abolished when CGS21680 (10 nM) was present during S1 and S2, whereas the facilitatory effect of CGS21680 was not modified when CPA (100 nM) was present in S1 and S2. Coapplication of CPA (100 nM) and CGS (10 nM) in S2 facilitated the evoked release of glutamate. The dashed bar illustrates the arithmetic sum of the effects of 10 nM CGS21680 and 100 nM CPA, if these effects were purely additive. The results are means Ϯ SEM of three to seven experiments. *p Ͻ 0.05 versus 0%; **p Ͻ 0.05 between bars. b, Increasing concentrations of adenosine (0.1-100 M) produced a biphasic effect, with with low and high concentrations inhibiting and stimulating the evoked release of glutamate, respectively. The results are means Ϯ SEM of six to eight experiments. *p Ͻ 0.05 versus 0%.
[ 3 H]CGS21680, K D values for the binding of CGS21680 to A 2A R in control and caffeine-treated animals were 111 Ϯ 43 and 120 Ϯ 60 nM, respectively. However, A 2A Rs displayed a lower affinity for caffeine in membranes from caffeine-pretreated rats (K D ϭ 290 Ϯ 80 M) compared with control rats (K D ϭ 80 Ϯ 10 M). This effect was significant ( p Ͻ 0.001) and specific for A 2A Rs, because the A 1 Rs had the same affinity for caffeine in both naive and caffeine-treated animals (K D ϭ 19 Ϯ 5 and 13 Ϯ 6 M).
Discussion
Either A 1 Rs or A 2A Rs are capable of forming heteromers with other G-protein receptors, such as dopamine, glutamate, and ATP receptors . However, the existence of heteromers constituted by different adenosine receptor subtypes had not been reported. In the present study, a precise colocalization of A 1 Rs and A 2A Rs at the presynaptic level of striatal glutamatergic synapses was demonstrated by ultrastructural analysis. The results of immunocytochemistry and coimmunoprecipitation experiments showed that the striatal A 1 R-A 2A R heteromer is preferentially localized in the striatal glutamatergic terminals, and the experiments of evoked glutamate release directly demonstrated the ability of presynaptic A 2A Rs to control the A 1 Rmediated modulation of striatal glutamate release. Radioligandbinding experiments demonstrated that a main biochemical characteristic of the A 1 R-A 2A R heteromer is the ability of A 2A R activation to reduce the affinity of the A 1 R for agonists. Together, the present results indicate that the A 1 R-A 2A R heteromer plays a role in the adenosine-mediated fine-tuning modulation of striatal glutamatergic neurotransmission.
Under basal conditions, the relatively low extracellular levels of adenosine preferentially stimulate A 1 Rs, which show a higher affinity for adenosine than A 2A Rs (Fredholm et al., 2001 ). The preferential A 1 R stimulation in the A 1 R-A 2A R heteromer inhibits glutamatergic neurotransmission. Under conditions of stronger adenosine release, A 2A receptor activation in the A 1 R-A 2A R heteromer would block A 1 R-mediated function, and the overall result will be a facilitation of the evoked release of glutamate (supplemental figure, available at www.jneurosci.org as supplemental material). Thus, the functional characteristics of the A 1 R-A 2A R heteromers are different from A 1 or A 2A receptors and provide a rationale to understand how adenosine might facilitate or inhibit glutamatergic transmission depending on the concentration of adenosine. In fact, increasing concentrations of adenosine demonstrated a biphasic effect, with low and high concentrations of adenosine inhibiting and stimulating glutamate release from striatal nerve terminals, respectively.
The present study also provides new information about the main pharmacological targets of caffeine, A 1 Rs and A 2A Rs. To our knowledge, this is the first study that analyses simultaneously the affinity of A 1 Rs and A 2A Rs for caffeine in transfected cells and brain (striatal) tissue. Previous studies using cloned transfected receptors showed that A 2A R displays higher affinity for caffeine than A 1 R (Fredholm et al., , 2001 . In contrast, the results obtained from brain tissue are more variable, showing either no difference (Muller et al., 1997) , a preferential affinity of A 2A R (Svenningsson et al., 1999) , or a preferential affinity of A 1 R for caffeine . Significant differences in the affinity of A 2A R for caffeine were observed depending on its selective association with A 1 R. In agreement with previous studies (Fredholm et al., 2001) , A 2A Rs display higher affinity for caffeine than A 1 Rs when studied in single-transfected cells. However, A 1 R-A 2A R, but not A 2A R-D 2 R, heteromerization was associated with a prominent decrease in the affinity of A 2A R for caffeine, with a K D value comparable with that observed in striatal tissue.
Taking also into account that the "biochemical fingerprint" of the A 1 R-A 2A R heteromer (the ability of A 2A R activation to reduce the affinity of the A 1 R for agonists) could be demonstrated in striatal membrane preparations, the present results indicate that a significant amount of striatal A 2A receptors are forming heteromers with A 1 Rs. However, although most A 1 Rs and A 2A Rs localized in the glutamatergic terminals are forming part of A 1 R-A 2A R heteromers, in the striatum caffeine can also target A 2A Rs not interacting with A 1 Rs localized in the dendritic spine of GABAergic enkephalinergic neurons (Rosin et al., 2003) , where they can form heteromers with dopamine D 2 R or metabotropic mGlu 5 receptors Agnati et al., 2003; Canals et al., 2003) . In fact, A 2A R in the A 2A -D 2 R heteromer has a higher affinity for caffeine than the A 2A R in the A 1 R-A 2A R heteromer ( Table  1 ). The blockade of these postsynaptic A 2A Rs could explain the decrease in the striatal expression of immediate-early genes and preproenkephalin mRNA and increased phosphorylation of DARPP-32 (dopamine-and cAMP-regulated phosphoprotein 32) (at threonine 75) described after acute caffeine treatments (Svenningsson et al., 1995; Lindskog et al., 2002) .
The functional characteristics of the A 1 R-A 2A R heteromers also allow understanding the different effects operated under acute and chronic caffeine administration. Because at relatively low adenosine levels there is little occupancy of A 2A Rs, most of the behavioral and biochemical effects after an acute administration of caffeine are most probably attributable to A 1 R blockade (Snyder et al., 1981; Solinas et al., 2002 Solinas et al., , 2005 Karcz-Kubicha et al., 2003; Quarta et al., 2004a,b; Antoniou et al., 2005) . In fact, the acute systemic or intrastriatal administration of caffeine enhances striatal glutamate release (Solinas et al., 2002; Quarta et al., 2004a,b) . A significant finding of the present study was the increased antagonistic interaction between A 1 R and A 2A R in the A 1 R-A 2A R heteromer with chronic caffeine treatment. But, apart from the affinity of the A 1 R and A 2A R for adenosine and caffeine and the A 1 R-A 2A R intramembrane interaction, one more variable plays a substantial role when analyzing the effects taking place after chronic caffeine administration. Chronic treatment with the methylxanthine leads to an increase in the plasma and extracellular levels of adenosine (Conlay et al., 1997; Andresen et al., 1999) . The same treatment with caffeine (1 mg/ml in the drinking water for 14 d) used in the present study was reported to produce a 10-fold increase in plasma adenosine levels (Conlay et al., 1997) . Under chronic caffeine treatment (or other conditions leading to increased adenosine levels), adenosine also binds and activates A 2A R, which, in addition, has a reduced affinity for caffeine. This likely scenario would lead to a situation in which the increased levels of adenosine acting on A 2A R would potently inhibit A 1 R function by means of the increased A 1 R-A 2A R intramembrane interaction. Under these conditions, caffeine would have little effect on A 1 Rs, which would already be inhibited as a consequence of the increased A 1 R-A 2A R intramembrane intermolecular interaction. In fact, recent studies show a predominant A 2A R antagonist behavioral and biochemical profile of caffeine under chronic administration with tolerance to its A 1 R antagonistic effects (Karcz-Kubicha et al., 2003; Quarta et al., 2004a) . The present results suggest that an increased A 1 R-A 2A R interaction in the A 1 R-A 2A R heteromer is involved in the tolerance to the psychostimulant effects of caffeine.
In conclusion, we have demonstrated that A 1 Rs and A 2A Rs can form heteromers in striatum where they modulate glutamatergic neurotransmission and whose existence may help in comprehending the mechanisms underlying the behavioral effects pro-
